Please use this identifier to cite or link to this item:
Title: Inhibitors of the M2 channel of influenza A virus
Author: Duque, María D.
Torres Costa, Eva
Valverde Murillo, Elena
Barniol-Xicota, Marta
Guardiola Bagán, Salvador
Rey Carrizo, Matías
Vázquez Cruz, Santiago
Keywords: Influenzavirus
Resistència als medicaments
Inhibidors enzimàtics
Influenza viruses
Drug resistance
Enzyme inhibitors
Issue Date: 2011
Publisher: Transworld Research Network
Abstract: Influenza is a highly contagious, major respiratory tract disease affecting millions of people each year. At present, two classes of antivirals are available: the neuraminidase inhibitors and the M2 proton channel blockers amantadine and rimantadine. However, rapid emergence of M2 blockers resistance makes imperative the development of new anti-influenza drugs. In the last few years several groups have synthesized and evaluated several analogs of amantadine. While several of them are active against wild-type M2 channel only a few are able to inhibit the mutant ion channels that lead to amantadine-resistance.
Note: Podeu consultar el llibre complet a:
Note: Reproducció del capítol 2 del llibre publicat a:
It is part of: Recent Advances in Pharmaceutical Sciences, 2011, Chapter 2, p. 35-64. Editor: Diego Muñoz-Torrero
Related resource:
Appears in Collections:Llibres / Capítols de llibre (Farmacologia, Toxicologia i Química Terapèutica)

Files in This Item:
File Description SizeFormat 
257179.pdf477.67 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.